REPORT ID 2422

EMEA (Europe, Middle East and Africa) Self-administered Drugs Market Report 2017

Publish Date
8-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Self-administered Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Self-administered Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Self-administered Drugs market competition by top manufacturers/players, with Self-administered Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Bristol-Myers Squibb
    Novartis AG
    Eli Lilly and Company
    Gilead Sciences
    Antares Pharma
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Injectable Drugs
    Inhaled Drugs
    Transdermal Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cardiovascular Diseases
    Diabetes
    Osteoporosis
    Pain Management
    Hormone Replacement
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Self-administered Drugs Market Report 2017
1 Self-administered Drugs Overview
    1.1 Product Overview and Scope of Self-administered Drugs
    1.2 Classification of Self-administered Drugs
        1.2.1 EMEA Self-administered Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Self-administered Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Injectable Drugs
        1.2.4 Inhaled Drugs
        1.2.5 Transdermal Drugs
    1.3 EMEA Self-administered Drugs Market by Application/End Users
        1.3.1 EMEA Self-administered Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Cardiovascular Diseases
        1.3.3 Diabetes
        1.3.4 Osteoporosis
        1.3.5 Pain Management
        1.3.6 Hormone Replacement
        1.3.7 Others
    1.4 EMEA Self-administered Drugs Market by Region
        1.4.1 EMEA Self-administered Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Self-administered Drugs (2012-2022)
        1.5.1 EMEA Self-administered Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Self-administered Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Self-administered Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Self-administered Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Self-administered Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Self-administered Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Self-administered Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Self-administered Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Self-administered Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Self-administered Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Self-administered Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Self-administered Drugs (Volume) by Application
    2.4 EMEA Self-administered Drugs (Volume and Value) by Region
        2.4.1 EMEA Self-administered Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Self-administered Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Self-administered Drugs Sales Price by Region (2012-2017)

3 Europe Self-administered Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Self-administered Drugs Sales and Value (2012-2017)
        3.1.1 Europe Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Self-administered Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Self-administered Drugs Sales and Market Share by Type
    3.3 Europe Self-administered Drugs Sales and Market Share by Application
    3.4 Europe Self-administered Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Self-administered Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Self-administered Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Self-administered Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Self-administered Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Self-administered Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Self-administered Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Self-administered Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Self-administered Drugs Sales and Growth Rate (2012-2017)

4 Middle East Self-administered Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Self-administered Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Self-administered Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Self-administered Drugs Sales and Market Share by Type
    4.3 Middle East Self-administered Drugs Sales and Market Share by Application
    4.4 Middle East Self-administered Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Self-administered Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Self-administered Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Self-administered Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Self-administered Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Self-administered Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Self-administered Drugs Sales and Growth Rate (2012-2017)

5 Africa Self-administered Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Self-administered Drugs Sales and Value (2012-2017)
        5.1.1 Africa Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Self-administered Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Self-administered Drugs Sales and Market Share by Type
    5.3 Africa Self-administered Drugs Sales and Market Share by Application
    5.4 Africa Self-administered Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Self-administered Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Self-administered Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Self-administered Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Self-administered Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Self-administered Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Self-administered Drugs Sales and Growth Rate (2012-2017)

6 EMEA Self-administered Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Laboratories
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Self-administered Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Self-administered Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Novartis AG
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Self-administered Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lilly and Company
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Self-administered Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Gilead Sciences
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Self-administered Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Antares Pharma
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Self-administered Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Self-administered Drugs Manufacturing Cost Analysis
    7.1 Self-administered Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Self-administered Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Self-administered Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Self-administered Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Self-administered Drugs Market Forecast (2017-2022)
    11.1 EMEA Self-administered Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Self-administered Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Self-administered Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Self-administered Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Self-administered Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Self-administered Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer